跳至主要内容
临床试验/NCT03764592
NCT03764592已完成不适用

Mapping of Ventricular Fibrillation (VF) Substrates and VF Arrhythmogenic Sources/Reentrant Circuits in Patients With Brugada and Early Repolarization Syndromes

Pacific Rim Electrophysiology Research Institute2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2018年2月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
2
主要终点
VF death

研究概览

简要总结

To determine the values and limitations of ECGI in guiding ablation and risk stratification in patients with BrS and Early Repolarization.

详细描述

The investigators will study symptomatic BrS and ERs syndrome (N=25) and asymptomatic patients (N=25) age between 16-70 years old to determine values and limitations of non-invasive mapping using electrocardiographic imaging (ECGI) in identifying VF substrates as target sites for catheter ablations in patients with Brugada (BrS) and Early repolarization syndromes (ERS) and also determine the mechanisms of VF in BrS and ERs syndromes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
16 Years 至 70 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients presenting with the type1 BrS ECG or ER ECG signature pattern, with/without a sodium channel blocker. Patients with the following one of these symptoms or arrhythmias will be considered as symptomatic patients: 1) aborted cardiac arrest cases, 2) documented VF episodes, 3) agonal respiration during sleep with difficulty to arouse, 4) syncope of unknown origin, or 5) seizure suspected of arrhythmic origin.•

排除标准

  • Patients who refuse informed consent and to participate to the best ability in the study.
  • Patients who have structural heart disease or concomitant medical illness.

结局指标

主要结局

VF death

时间窗: 3 years

ventricular fibrillation

次要结局

未报告次要终点

研究者

发起方
Pacific Rim Electrophysiology Research Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Koonlawee Nademanee, MD

Principal Investigator

Pacific Rim Electrophysiology Research Institute

研究点 (2)

Loading locations...

相似试验